Showing results (41-50 of 329) with videos related to
Sort By:
Pageof 33
Lung Cancer (Amsterdam, Netherlands)|April 8, 2010
Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancerPaul Maddison, Alison Thorpe, Paul Silcocks, et al.Core Evidence|January 12, 2011
Arzoxifene: the evidence for its development in the management of breast cancerLee R Jackson, Kwok L Cheung, Aman U Buzdar, et al.Cancer Cell|August 25, 2004
Successful targeting of ErbB2 receptors-is PTEN the key?Robert J Crowder, Donald P Lombardi, Matthew J EllisSurgical Oncology Clinics of North America|July 13, 2010
Neoadjuvant endocrine therapy for breast cancerJane S Chawla, Cynthia X Ma, Matthew J EllisThe Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effectMatthew J Ellis, Eric Rosen, Holly Dressman, et al.Chinese Clinical Oncology|September 27, 2015
The ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2- invasive breast cancerVera Jean Suman, Matthew J Ellis, Cynthia X MaSteroids|March 23, 2011
Importance of PI3-kinase pathway in response/resistance to aromatase inhibitorsCynthia X Ma, Robert J Crowder, Matthew J EllisThe Breast Journal|January 14, 2004
Dramatic response of choroidal metastases from breast cancer to a combination of trastuzumab and vinorelbineZee-Wan Wong, Steven J Phillips, Matthew J EllisOncology (Williston Park, N.Y.)|March 28, 2009
Predicting endocrine therapy responsiveness in breast cancerCynthia X Ma, Cesar G Sanchez, Matthew J EllisJournal of Oncology|August 29, 2013
Neoadjuvant therapy in operable breast cancer: application to triple negative breast cancerFoluso O Ademuyiwa, Matthew J Ellis, Cynthia X MaPageof 33